Dr. Emiko Quinn

General neurologist · A.C. Camargo Cancer Center · Brazil (BR) · Neurology

Tier 2STK-0112GoodOwner MSL LOLuis Ortega

Data minimisation

Consent status: Pending. The name shown may be a pseudonym. Contact details, personal identifiers and remuneration fields are hidden for your role; only scientific-profile fields needed for engagement planning are displayed.

Specialty: Headache medicine
Disease interests: MIG
Scientific interests: SwitchingChronic migraineCGRP persistence
Engagement preference: In person
Advisory boards: 1
Publications: 11
Source system: Veeva CRM
Data quality: Good

Engagement plan

Cadence target for Tier 2: 2 per year (assumption)

Last engaged: 05 Aug 2026 (41 days ago)
Next planned contact: 04 Feb 2027
Last 6 months vs target: 100%
1 of 1 expected engagements

Insights from this stakeholder (0)

No insights captured from engagements with this stakeholder.

Engagement history (2)

All engagements including drafts, newest first

Date	Type	Format	MSL	Product	Topics	Insights	Flags	Status
05 Aug 2026	Congress meeting	Phone	Luis Ortega	Lumeva	Chronic migraine dataSwitching between CGRP agents	0	—	Reviewed	ENG-0226
03 Feb 2026	Payer / HTA meeting	In person	Luis Ortega	Lumeva	Drug interactionsSwitching between CGRP agents+1	0	—	Reviewed	ENG-0192

Timeline

05 Aug 2026
Congress meeting
Chronic migraine data, Switching between CGRP agents
03 Feb 2026
Payer / HTA meeting
Drug interactions, Switching between CGRP agents, Real-world persistence

Related stakeholders (0)

A.C. Camargo Cancer Center

No other stakeholders at this institution.